S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model
- PMID: 32017036
- DOI: 10.1002/eji.201948349
S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model
Abstract
The sphingolipid sphingosine-1-phosphate (S1P) fulfills distinct functions in immune cell biology via binding to five G protein-coupled receptors. The immune cell-specific sphingosine-1-phosphate receptor 4 (S1pr4) was connected to the generation of IL-17-producing T cells through regulation of cytokine production in innate immune cells. Therefore, we explored whether S1pr4 affected imiquimod-induced murine psoriasis via regulation of IL-17 production. We did not observe altered IL-17 production, although psoriasis severity was reduced in S1pr4-deficient mice. Instead, ablation of S1pr4 attenuated the production of CCL2, IL-6, and CXCL1 and subsequently reduced the number of infiltrating monocytes and granulocytes. A connection between S1pr4, CCL2, and Mϕ infiltration was also observed in Zymosan-A induced peritonitis. Boyden chamber migration assays functionally linked reduced CCL2 production in murine skin and attenuated monocyte migration when S1pr4 was lacking. Mechanistically, S1pr4 signaling synergized with TLR signaling in resident Mϕs to produce CCL2, likely via the NF-κB pathway. We propose that S1pr4 activation enhances TLR response of resident Mϕs to increase CCL2 production, which attracts further Mϕs. Thus, S1pr4 may be a target to reduce perpetuating inflammatory responses.
Keywords: Mϕs; S1PR4; psoriasis.
© 2020 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Sphingosine-1-Phosphate Receptor 4 links neutrophils and early local inflammation to lymphocyte recruitment into the draining lymph node to facilitate robust germinal center formation.Front Immunol. 2024 Aug 12;15:1427509. doi: 10.3389/fimmu.2024.1427509. eCollection 2024. Front Immunol. 2024. PMID: 39188715 Free PMC article.
-
S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.J Immunol. 2016 Feb 15;196(4):1579-90. doi: 10.4049/jimmunol.1403168. Epub 2016 Jan 18. J Immunol. 2016. PMID: 26783340
-
Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages.J Microbiol. 2015 Dec;53(12):864-74. doi: 10.1007/s12275-015-5348-1. Epub 2015 Dec 2. J Microbiol. 2015. PMID: 26626357
-
Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation.Mediators Inflamm. 2017;2017:6059203. doi: 10.1155/2017/6059203. Epub 2017 Aug 7. Mediators Inflamm. 2017. PMID: 28848247 Free PMC article. Review.
-
S1P-S1PR1 Signaling: the "Sphinx" in Osteoimmunology.Front Immunol. 2019 Jun 25;10:1409. doi: 10.3389/fimmu.2019.01409. eCollection 2019. Front Immunol. 2019. PMID: 31293578 Free PMC article. Review.
Cited by
-
Sphingosine-1-Phosphate Receptor 4 links neutrophils and early local inflammation to lymphocyte recruitment into the draining lymph node to facilitate robust germinal center formation.Front Immunol. 2024 Aug 12;15:1427509. doi: 10.3389/fimmu.2024.1427509. eCollection 2024. Front Immunol. 2024. PMID: 39188715 Free PMC article.
-
Tanshinol ameliorates imiquimod-induced psoriasis by inhibiting M1 macrophage polarization through suppression of the notch signaling pathway.Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8745-8758. doi: 10.1007/s00210-024-03166-9. Epub 2024 Jun 4. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38832986 Free PMC article.
-
Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.Cell Commun Signal. 2024 May 2;22(1):251. doi: 10.1186/s12964-024-01626-6. Cell Commun Signal. 2024. PMID: 38698424 Free PMC article. Review.
-
Signaling pathways and targeted therapies for psoriasis.Signal Transduct Target Ther. 2023 Nov 27;8(1):437. doi: 10.1038/s41392-023-01655-6. Signal Transduct Target Ther. 2023. PMID: 38008779 Free PMC article. Review.
-
The Role of Sphingolipids and Sphingosine-1-phosphate-Sphingosine-1-phosphate-receptor Signaling in Psoriasis.Cells. 2023 Sep 26;12(19):2352. doi: 10.3390/cells12192352. Cells. 2023. PMID: 37830566 Free PMC article. Review.
References
-
- Olesch, C., Ringel, C., Brüne, B. and Weigert, A., Beyond immune cell migration: the emerging role of the sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation. Mediators Inflamm. 2017. 2017: 6059203-6059212.
-
- Schulze, T., Golfier, S., Tabeling, C., Räbel, K., Gräler, M. H., Witzenrath, M. and Lipp, M., Sphingosine-1-phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J. 2011. 25: 4024-4036.
-
- Nograles, K. E., Zaba, L. C., Yassky, E. G., Duculan, J. F., Fariñas, M. S., Cardinale, I., Khatcherian, A. et al., Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 2008. 159: 1092-1102.
-
- Schaper, K., Dickhaut, J., Japtok, L., Kietzmann, M., Mischke, R., Kleuser, B. and Bäumer, W., Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J. Dermatol. Sci. 2013. 71: 29-36.
-
- Krause, A., D'Ambrosio, D. and Dingemanse, J., Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis. J. Dermatol. Sci. 2018. 89: 136-145.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases